The effect of cytokines, including IL4, IL7, stem cell factor, insulin-like growth factor on childhood acute

R Consolini1, A Legitimo, M Cattani

  • 1Department of Pediatrics, University of Pisa, Italy.

Leukemia Research
|August 1, 1997
PubMed

Insights

Interleukin 7 (IL7) and other growth factors show varied effects on acute lymphoblastic leukemia (ALL) cell growth and differentiation. Some ALL cells responded to IL7, with limited maturation observed in others, while IL4, SCF, and IGF-1 had minimal impact.

Area of Science:

  • Hematology
  • Immunology
  • Oncology

Background:

  • Human lymphopoiesis involves key cytokines like IL7, SCF, and IGF-1.
  • Acute lymphoblastic leukemia (ALL) is a cancer of immature lymphocytes.
  • Pre-B cell lines and primary ALL blasts are used to study leukemia development.

Purpose of the Study:

  • To investigate the effects of IL4, IL7, SCF, and IGF-1 on ALL cell proliferation, clonal growth, and differentiation.
  • To determine the potential of these cytokines to induce maturation in ALL cells.
  • To explore the role of these factors in B-cell precursor ALL (BCP ALL).

Main Methods:

  • Culturing Nalm 1 and Nalm 6 pre-B cell lines.
  • Analyzing purified blasts from 37 childhood ALL patients.
  • Assessing cell proliferation, clonal growth, and differentiation markers (surface immunoglobulins, terminal deoxynucleotidyl transferase, cALL antigen) after cytokine treatment.

Main Results:

  • IL4 showed no promoting activity and inhibited growth in some patients.
  • IL7 induced proliferation and clonal growth in a minority of ALL cases, with heterogeneous responses.
  • IL7 demonstrated potential for limited ALL cell maturation, indicated by changes in differentiation markers, but did not consistently induce surface immunoglobulin expression.
  • SCF did not enhance IL7 response in BCP ALL.
  • IGF-1 alone or with IL7 did not induce proliferation or clonal growth in BCP ALL.

Conclusions:

  • Cytokine responsiveness in ALL cells is highly variable.
  • IL7 may possess limited differentiation-inducing capacity in a subset of ALL patients.
  • SCF and IGF-1 do not appear to be effective in promoting proliferation or growth in BCP ALL under these conditions.

Related Concept Videos

Lineage Commitment01:21

Lineage Commitment

Commitment is the  process whereby stem cells:
Differentiation of Common Myeloid Progenitor Cells01:15

Differentiation of Common Myeloid Progenitor Cells

Common myeloid progenitors (CMPs) are oligopotent cells that can differentiate into granulocytes and macrophages. Granulocytes and macrophages are essential for protecting the body against bacterial, viral, or fungal infections. They migrate from the bone marrow into the circulating blood to reach specific tissue sites where they differentiate and help in immune surveillance. However, they survive only for a few days and must be continuously made available to the organism to maintain a robust...
Regulation of Hematopoietic Stem Cells01:01

Regulation of Hematopoietic Stem Cells

All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
Stem Cell Therapy for Tissue Regeneration01:21

Stem Cell Therapy for Tissue Regeneration

Stem cell therapy is a method used in regenerative medicine to repair and restore function to damaged tissues and organs. Stem cells have the potential to proliferate and differentiate into various tissue types, making them ideal candidates for tissue regeneration. For example, hematopoietic stem cell transplants are commonly used in blood cancer treatment to replenish damaged bone marrow and restore healthy blood cells.
Types of Stem Cells used in Stem Cell Therapy
The two main cell types that...
Disorders of Leukocytes01:27

Disorders of Leukocytes

Leukocyte disorders can lead to either leukopenia, characterized by an abnormally low leukocyte count, or leukocytosis, marked by a very high leukocyte number.
Leukopenia may result from bone marrow disorders, autoimmune diseases, and infectious diseases. For example, conditions such as multiple myeloma and aplastic anemia can impair the bone marrow's ability to produce adequate leukocytes. Similarly, autoimmune diseases like lupus and viral infections such as HIV can prompt the immune system...